Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Study on Early Onset Melanoma and Germ-Line Mutation in Cdkn2a Among Patients in Imam Khomeini Hospital Complex
Maryam Daneshpajooh
Maryam Daneshpajooh

Professor of Dermatology

Department Dermatology

School of Medicine

Razi Hospital

Autoimmune Bullous Diseases Research Center

Tehran University of Medical Sciences

Related Documents
1. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
All Documents
1. Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study, Dermatology Practical and Conceptual (2025)
2. Are Sites of Primary Lesions in Pemphigus Vulgaris More Prone to Relapse?, Oral Diseases (2024)
3. Dna Repair-Related Heritable Photosensitivity Syndromes: Mutation Landscape in a Multiethnic Cohort of 17 Multigenerational Families With High Degree of Consanguinity, DNA Repair (2024)
4. Impairment of Sexual Function in Patients With Pemphigus, Journal of the European Academy of Dermatology and Venereology (2024)
5. Investigating the Impact of Added Profhilo Mesogel to Subcision Versus Subcision Monotherapy in Treating Acne Scars; a Single-Blinded, Split-Face Randomized Trial, Journal of Cosmetic Dermatology (2024)
6. Pemphigus Vulgaris, Mayo Clinic Proceedings (2024)
7. What Is Novel in the Clinical Management of Pemphigus Vulgaris?, Expert Review of Clinical Pharmacology (2024)
8. A Systematic Review on Efficacy, Safety and Treatment Durability of Intravenous Immunoglobulin in Autoimmune Bullous Dermatoses: Special Focus on Indication and Combination Therapy, Experimental Dermatology (2023)
9. Anatomic Evaluation of the Normal Variants of the Arteries of Face Using Color Doppler Ultrasonography: Implications for Facial Aesthetic Procedures, Journal of Cosmetic Dermatology (2023)
10. Association of Alternative Healthy Eating Index and Severity of Pemphigus Vulgaris: A Crosssectional Study, PLoS ONE (2023)
11. Characteristics of Patients Admitted to a Dermatology Emergency Unit in Tehran, Iran, During the Covid-19 Pandemic, Iranian Journal of Dermatology (2023)
12. Clinicopathological Characteristics of Bowen Disease: A 7-Year Study at a Referral Dermatology Hospital, Dermatology Practical and Conceptual (2023)
13. Comparing the Efficacy of Plasma Exeresis and Cryotherapy for the Treatment of Seborrheic Keratosis: A Randomized Controlled Trial, Skin Research and Technology (2023)
14. Corrigendum: S2k Guidelines on the Management of Paraneoplastic Pemphigus/Paraneoplastic Autoimmune Multiorgan Syndrome Initiated by the European Academy of Dermatology and Venereology (Eadv) (J Eur Acad Dermatol Venereol, 10.1111/Jdv.18931), Journal of the European Academy of Dermatology and Venereology (2023)
15. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)
16. Dermoscopy of Cutaneous Granulomatous Disorders: A Study of 107 Cases, Skin Research and Technology (2023)
17. Detection of Herpes Simplex Viruses in the Oral Lesions of Patients With Pemphigus Vulgaris: Is It Diagnostic or Predictive of Disease Severity?, Skin Health and Disease (2023)
18. Drug Adherence and Its Association With Health Literacy Among Patients With Autoimmune Bullous Diseases, Journal of Clinical and Aesthetic Dermatology (2023)
19. Drug-Induced Cutaneous Pseudolymphoma: A Systematic Review of the Literature, Australasian Journal of Dermatology (2023)
20. Editorial: Challenges of Covid-19 in Dermatology Patients on Immunosuppression: Risk, Outcome, Vaccination and Beyond, Volume Ii, Frontiers in Medicine (2023)
21. Elevated Serum Level of B-Cell Activating Factor (Baff) After Rituximab Therapy in Pemphigus Vulgaris Patients Suggests a Possible Therapeutic Efficacy of B-Cell Depletion Therapies Combined With Anti-Baff Agents, International Journal of Dermatology (2023)
22. Factors Associated With the Healing Time of Pemphigus Vulgaris Oral Lesions: A Prospective Study, Oral Diseases (2023)
23. Infections in Hospitalized Patients With Psoriasis in a Skin Referral Hospital, Dermatology Practical and Conceptual (2023)
24. L-Carnitine Downregulate the Muscle Wasting Effect of Glucocorticoids in Pemphigus Patient: A Randomized Double-Blind Placebo-Controlled Study, Physiological Reports (2023)
25. Nail Abnormalities in Subepidermal Blistering Diseases: A Cross-Sectional Study, International Journal of Dermatology (2023)
26. Odss Vs. Absis and Pdai Oral Parts in Pemphigus Vulgaris: Inter-Rater Reliability and Testing Times, Oral Diseases (2023)
27. Pemphigus Disease and Area Index: Unmet Needs in the Real-World Management of Pemphigus, Oral Diseases (2023)
28. Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients, JDDG - Journal of the German Society of Dermatology (2023)
29. Rituximab Zur Behandlung Von Epidermolysis Bullosa Acquisita: Eine Große Fallserie Mit 15 Patienten, JDDG - Journal of the German Society of Dermatology (2023)
30. S2k Guidelines on the Management of Paraneoplastic Pemphigus/Paraneoplastic Autoimmune Multiorgan Syndrome Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2023)
31. Serologic Biomarkers in Pemphigus Monitoring: C-Reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays, Iranian Journal of Allergy# Asthma and Immunology (2023)
32. Treatment Resistance to Tnf- Α Inhibitors in Patients With Psoriasis, Dermatologic Therapy (2023)
33. A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum, Dermatologic Therapy (2022)
34. Adverse Outcome and Severity of Covid-19 in Patients With Autoimmune Bullous Diseases: A Historical Cohort Study, Dermatologic Therapy (2022)
35. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)
36. Assessing Quality of Life in Patients With Autoimmune Bullous Diseases Using the Persian Version of Treatment of Autoimmune Bullous Disease Quality of Life Questionnaire Finds Similar Effects in Women As Men, International Journal of Women's Dermatology (2022)
37. Assessment of Health-Related Quality of Life in Patients With Frontal Fibrosing Alopecia, Journal of Cosmetic Dermatology (2022)
38. Blistering Disorders and Their Impact on Women and Their Families in the International Journal of Women S Dermatology: Honoring the Contributions of Professor Dedee Murrell, International Journal of Women's Dermatology (2022)
39. Burden of Pemphigus Vulgaris With a Particular Focus on Women: A Review, International Journal of Women's Dermatology (2022)
40. Clinical and Serological Characterization of Orf-Induced Immunobullous Disease, JAMA Dermatology (2022)
41. Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey, Case Reports in Dermatology (2022)
42. Comparing Efficacy and Safety of Potassium Hydroxide 5% Solution With 5-Fluorouracil Cream in Patients With Actinic Keratoses: A Randomized Controlled Trial, Journal of Dermatological Treatment (2022)
43. Comparison of the Efficacy and Safety of 308-Nm Excimer Laser With Intralesional Corticosteroids for the Treatment of Alopecia Areata: A Randomized Controlled Study, Lasers in Surgery and Medicine (2022)
44. Editorial: Challenges of Covid-19 in Dermatology Patients on Immunosuppression: Risk, Outcome, Vaccination, and Beyond, Frontiers in Medicine (2022)
45. Efficacy and Safety of Oral Pioglitazone in the Management of Lichen Planopilaris in Comparison With Clobetasol: A Randomized Clinical Trial, Dermatologic Therapy (2022)
46. Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran, Dermatologic Therapy (2022)
47. Evaluating the Risk-To-Benefit Ratio of Using Cotrimoxazole As a Pneumocystis Pneumonia Preventative Intervention Among Pemphigus Patients Treated With Rituximab: A Retrospective Study With 494 Patients, Dermatologic Therapy (2022)
48. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?, Frontiers in Medicine (2022)
49. How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey, JID Innovations (2022)
50. International Dermoscopy Society Criteria for Non-Neoplastic Dermatoses (General Dermatology): Validation for Skin of Color Through a Delphi Expert Consensus, International Journal of Dermatology (2022)
51. Lichen Planopilaris: Histopathological Survey of 70 Vertical Sections of Scalp Biopsies, Iranian Journal of Dermatology (2022)
52. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)
53. Oral Isotretinoin Combined With Topical Clobetasol 0.05% and Tacrolimus 0.1% for the Treatment of Frontal Fibrosing Alopecia: A Randomized Controlled Trial, Journal of Dermatological Treatment (2022)
54. Pemphigus Patients With Initial Negative Levels of Anti-Desmoglein: A Subtype With Different Profile?, Dermatologic Therapy (2022)
55. Pregnancy Outcomes in Women With Pemphigus Exposed to Rituximab Before or During Pregnancy, International Journal of Women's Dermatology (2022)
56. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)
57. Punctate Pattern and Pemphigus: Is There Any Evidence of Punctate Pattern Among Iranian Patients?, American Journal of Dermatopathology (2022)
58. Pustular Eruption After Biosimilar Rituximab Infusion: Report of Acute Generalized Exanthematous Pustulosis in Two Patients With Pemphigus, International Journal of Dermatology (2022)
59. Recurrent Aphthous Stomatitis, Diseases of the Oral Mucosa: Study Guide and Review (2022)
60. Remission of Prurigo Pigmentosa After Breaking Ketogenic Diet and Resuming Regular Diet, Advanced Biomedical Research (2022)
61. Remission of Prurigo Pigmentosa After Breaking Ketogenic Diet and Resuming Regular Diet, Advanced Biomedical Research (2022)
62. Retrospective Study of Gingival Involvement in Pemphigus: A Difficult to Treat Phenomenon, Dermatologic Therapy (2022)
63. Rituximab Monotherapy in Mild Pemphigus, Journal of Dermatological Treatment (2022)
64. Self-Assessment Pemphigus Vulgaris Activity Score (Sa-Pvas): A New Tool for Patients to Self-Assess Their Disease Severity, Australasian Journal of Dermatology (2022)
65. Stigma Experience in Patients With Vitiligo: A Comprehensive Study in a Skin Hospital, Acta Medica Iranica (2022)
66. The Efficacy of Rituximab in Patients With Mucous Membrane Pemphigoid, Journal of Dermatological Treatment (2022)
67. Treatment of Chronic Venous Ulcer With Cold Atmospheric Plasma Jet, Case Reports in Dermatology (2022)
68. Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2022)
69. A Systematic Review on Efficacy, Safety, and Treatment-Durability of Low-Dose Rituximab for the Treatment of Pemphigus: Special Focus on Covid-19 Pandemic Concerns, Immunopharmacology and Immunotoxicology (2021)
70. Authors' Reply to the Comment “Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic”, Journal of the American Academy of Dermatology (2021)
71. Characteristics and Outcomes of Covid-19 in Patients With Autoimmune Bullous Diseases: A Retrospective Cohort Study, Journal of the American Academy of Dermatology (2021)
72. Chronic Subungual Lesion in a Young Woman, Indian Journal of Dermatology# Venereology and Leprology (2021)
73. Clinical and Dermatoscopic Characteristics of Lichen Planus-Like Keratosis in a West-Asian Population, Australasian Journal of Dermatology (2021)
74. Correlation of Anti-Γ/Ε Nicotinic Acetylcholine Receptor Antibody Levels With Anti-Desmoglein 1,3 Antibody Levels and Disease Severity in Pemphigus Vulgaris, Clinical and Experimental Dermatology (2021)
75. Covid-19: The Experience From Iran, Clinics in Dermatology (2021)
76. Current Status and Prospects for the Diagnosis of Pemphigus Vulgaris, Expert Review of Clinical Immunology (2021)
77. Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, But Not Chronic Patients With Inactive Disease Compared to Healthy Controls, Dermatology Practical and Conceptual (2021)
78. Dermoscopic Evaluation of Longitudinal Melanonychia in Children: A Prospective Study, Indian Journal of Dermatology (2021)
79. Drug Sensitivity Profile of Fungi Isolated From Onychomycosis Patients and Evaluation of Squalene Epoxidase Mutation in One Terbinafine-Resistant Trichophyton Mentagrophytes Species, Microbial Drug Resistance (2021)
80. Drug-Induced Pemphigus: A Systematic Review of 170 Patients, International Immunopharmacology (2021)
81. Efficacy and Safety of Biosimilar Rituximab in Patients With Pemphigus Vulgaris: A Prospective Observational Study, Journal of Dermatological Treatment (2021)
82. Efficacy and Safety of Hydrogen Peroxide Topical Solution in Treating Actinic Keratosis: A Randomized Controlled Trial, Dermatologic Therapy (2021)
83. Epidermolysis Bullosa Acquisita: The Most Frequent Pemphigoid Disease in Patients With Dermal Binding Autoantibodies by Indirect Immunofluorescence Microscopy on Human Salt-Split Skin in Tehran, Iran, Journal of the European Academy of Dermatology and Venereology (2021)
84. Evaluating the Efficacy and Safety of Topical Sirolimus 0.2% Cream As Adjuvant Therapy With Pulsed Dye Laser for the Treatment of Port Wine Stain: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Cosmetic Dermatology (2021)
85. Immunosuppressive Drugs for Patients With Psoriasis During the Covid-19 Pandemic Era. a Review, Dermatologic Therapy (2021)
86. Lichen Planus-Like Lesions in 36 Patients With Pemphigus: A Cross-Sectional Study, Oral Diseases (2021)
87. Paradoxical Worsening of Pemphigus After Rituximab Presenting As Figurate Bullous Eruption, British Journal of Dermatology (2021)
88. Patchy Alopecia in a Patient With Rheumatoid Arthritis: A Practical Application of Trichoscopy, Case Reports in Dermatology (2021)
89. Pemphigus Scalp Lesions: Is Trichoscopy Helpful in Clinical Diagnosis?, International Journal of Dermatology (2021)
90. Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence, Journal of Iranian Medical Council (2021)
91. Rituximab Exhibits a Better Safety Profile When Used As a First Line of Treatment for Pemphigus Vulgaris: A Retrospective Study, International Immunopharmacology (2021)
92. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)
93. The Evaluation of Efficacy of Atmospheric Pressure Plasma in Diabetic Ulcers Healing: A Randomized Clinical Trial, Dermatologic Therapy (2021)
94. Toxic Epidermal Necrolysis in Pregnancy Due to Ondansetron With a Favorable Outcome: A Case Report and Review of the Literature, Journal of Clinical and Aesthetic Dermatology (2021)
95. Acute Generalized Exanthematous Pustulosis With a Focus on Hydroxychloroquine: A 10-Year Experience in a Skin Hospital, International Immunopharmacology (2020)
96. Adverse Electrocardiographic Effects of Rituximab Infusion in Pemphigus Patients, Dermatologic Therapy (2020)
97. An Unusual Case of Multibacillary Leprosy Mimicking Prurigo Nodularis, Clinical Case Reports (2020)
98. Autoimmune Bullous Disease Quality of Life (Abqol) Questionnaire: Validation of the Translated Persian Version in Pemphigus Vulgaris, International Journal of Women's Dermatology (2020)
99. Concomitant Bullous Pemphigoid and Palmoplantar Keratoderma: A Report of Three Cases and Review of Literature, Dermatologic Therapy (2020)
100. Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase, Dermatologic Therapy (2020)
101. Decreased Sox2 Messenger Rna Expression in Basal Cell Carcinoma, Indian Journal of Dermatology (2020)
102. Desquamative Gingivitis in a Pemphigus Vulgaris Patient Resistant to Rituximab, Dermatologic Therapy (2020)
103. Diagnosis and Management of Pemphigus: Recommendations of an International Panel of Experts, Journal of the American Academy of Dermatology (2020)
104. Diagnostic Value of Cytology in Oral Ulcer and Comparison With Histopathology and Direct Immunofluorescence, Dermatologic Therapy (2020)
105. Estimated Cut-Off Values for Pemphigus Severity Classification According to Pemphigus Disease Area Index (Pdai), Autoimmune Bullous Skin Disorder Intensity Score (Absis), and Anti-Desmoglein 1 Autoantibodies, BMC Dermatology (2020)
106. Family Impact of Pemphigus Disease in an Iranian Population Using the Family Dermatology Life Quality Index, International Journal of Women's Dermatology (2020)
107. Intralesional Injection of Biosimilar Rituximab in Recalcitrant Mucocutaneous Lesions of Patients With Pemphigus Vulgaris: A Pilot Study, Dermatologic Therapy (2020)
108. Investigating Expression Pattern of Eight Immune-Related Genes in Pemphigus Patients Compared With the Healthy Controls and After Rituximab Therapy: Potential Roles of Ctla4 and Fcgr3a Genes Expression in Outcomes of Rituximab Therapy, Dermatologic Therapy (2020)
109. Mucous Membrane Pemphigoid and Covid-19 Treated With High-Dose Intravenous Immunoglobulins: A Case Report, Journal of Dermatological Treatment (2020)
110. Multiple Giant Milia in Cutaneous Squamous Cell Carcinoma: A Rare Presentation, Australasian Journal of Dermatology (2020)
111. Paradoxical Reaction to Rituximab in Patients With Pemphigus: A Report of 10 Cases, Immunopharmacology and Immunotoxicology (2020)
112. Pathogenic and Protective Roles of Cytokines in Pemphigus: A Systematic Review, Cytokine (2020)
113. Rituximab in Childhood and Juvenile Autoimmune Bullous Diseases As First-Line and Second-Line Treatment: A Case Series of 13 Patients, Journal of Dermatological Treatment (2020)
114. Single-Nucleotide Polymorphisms Associated With Pemphigus Vulgaris: Potent Markers for Better Treatment and Personalized Medicine, International Journal of Immunogenetics (2020)
115. Successful Treatment of a Patient With Multicolored Nevus of Ota Using a Combination of 1064 and 532 Nm Q-Switched Nd:Yag Lasers, Journal of Cosmetic and Laser Therapy (2020)
116. Switching From Pemphigus Vulgaris to Psoriasis: A Rare Report of Three Cases, International Journal of Dermatology (2020)
117. The Effect of L-Carnitine Supplementation on Serum Levels of Omentin-1, Visfatin and Sfrp5 and Glycemic Indices in Patients With Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Phytotherapy Research (2020)
118. The Effect of L-Carnitine Supplementation on Serum Levels of Omentin-1, Visfatin and Sfrp5 and Glycemic Indices in Patients With Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Phytotherapy Research (2020)
119. Transition Between Pemphigus Vulgaris and Pemphigus Foliaceus: A 10-Year Follow-Up Study, JDDG - Journal of the German Society of Dermatology (2020)
120. Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era, Dermatologic Therapy (2020)
121. Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic, Journal of the American Academy of Dermatology (2020)
122. Treatment of Pemphigus Patients in the Covid-19 Era: A Specific Focus on Rituximab, Dermatologic Therapy (2020)
123. Updated S2k Guidelines on the Management of Pemphigus Vulgaris and Foliaceus Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2020)
124. A Case of Hidroacanthoma Simplex With New Dermoscopic Features, Indian Journal of Dermatology# Venereology and Leprology (2019)
125. A Case of Lepromatous Leprosy Clinically Masquerading As Vasculitis, Dermatology Practical and Conceptual (2019)
126. Angina Bullosa Haemorrhagica-Like Lesions in Pemphigus Vulgaris, Australasian Journal of Dermatology (2019)
127. Annular Lichenoid Dermatitis of Youth: Report on Two Adult Cases and One Child, JDDG - Journal of the German Society of Dermatology (2019)
128. Assessing the Correlation Between Trichoscopic Features in Lichen Planopilaris and Lichen Planopilaris Activity Index, Australasian Journal of Dermatology (2019)
129. Autosomal Recessive Congenital Ichthyosis: Genomic Landscape and Phenotypic Spectrum in a Cohort of 125 Consanguineous Families, Human Mutation (2019)
130. Biallelic Krt5 Mutations in Autosomal Recessive Epidermolysis Bullosa Simplex, Including a Complete Human Keratin 5 “Knock-Out”, Matrix Biology (2019)
131. Bulloses Pemphigoid Mit Linearen Lasionen Und Antikorpern Ausschließlich Gegen Die Losliche Ektodomane Von Bp180 (Lad-1), JDDG - Journal of the German Society of Dermatology (2019)
132. Bullous Pemphigoid With Linear Lesions and Antibodies Exclusively Against the Soluble Ectodomain of Bp180 (Lad-1), JDDG - Journal of the German Society of Dermatology (2019)
133. Comparing Early and Late Treatments With Rituximab in Pemphigus Vulgaris: Which One Is Better?, Archives of Dermatological Research (2019)
134. Comparing the Short-Term Therapeutic Effects and Safety Profiles of Rituximab Therapy in Pemphigus Vulgaris Patients Either Early Treated or Later Than Six Months, Journal of Dermatological Treatment (2019)
135. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
136. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
137. Epidermodysplasia Verruciformis: Genetic Heterogeneity and Ever1 and Ever2 Mutations Revealed by Genome-Wide Analysis, Journal of Investigative Dermatology (2019)
138. Frontal Fibrosing Alopecia: An Update on the Hypothesis of Pathogenesis and Treatment, International Journal of Women's Dermatology (2019)
139. Genome-Wide Single Nucleotide Polymorphism-Based Autozygosity Mapping Facilitates Identification of Mutations in Consanguineous Families With Epidermolysis Bullosa, Experimental Dermatology (2019)
140. Inter-Rater Reliability of the Biochip Indirect Immunofluorescence Dermatology Mosaic in Bullous Pemphigoid and Pemphigus Patients, Journal of the European Academy of Dermatology and Venereology (2019)
141. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)
142. Lichen Planopilaris: Retrospective Study on the Characteristics and Treatment of 291 Patients, Journal of Dermatological Treatment (2019)
143. Otophyma in a Woman: A Rare and Neglected Clinicopathological Entity, Australasian Journal of Dermatology (2019)
144. Post-Orf Epidermolysis Bullosa Acquisita, Journal of the European Academy of Dermatology and Venereology (2019)
145. Reply To: “Comment on ‘Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris'”, Journal of the American Academy of Dermatology (2019)
146. Short-Term Clinical and Serological Follow-Up With Conventional and Conformational Anti-Desmoglein Antibodies in Treatment-Naive and Previously Treated Patients With Pemphigus Vulgaris After Receiving Rituximab, International Journal of Women's Dermatology (2019)
147. The First Report of Pseudomonas Oryzihabitansin Infection in a Patient With Hidradenitis Suppurativa, Clinical Case Reports (2019)
148. Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris, Journal of the American Academy of Dermatology (2019)
149. Unexpected Worsening of Pemphigus Vulgaris After Rituximab: A Report of Three Cases, International Immunopharmacology (2019)
150. Upregulation of Snai2 and Sox9 Mrna Versus Downregulation of Eight Other Emt/Stemness Related Genes in Basal Cell Carcinoma, British Journal of Dermatology (2019)
151. “Change Over Time in the Treatment of Pemphigus Vulgaris Between 2004 and 2016 in Iran”: A Multiple Cross-Sectional Study, Dermatologic Therapy (2019)
152. Annular Asymptomatic Plaques in a Diabetic Boy, Journal of Iranian Medical Council (2018)
153. Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab, Dermatologic Therapy (2018)
154. Attenuation of Serotonin-Induced Itch by Sumatriptan: Possible Involvement of Endogenous Opioids, Archives of Dermatological Research (2018)
155. Bpdai and Absis Correlate With Serum Anti-Bp180 Nc16a Igg But Not With Anti-Bp230 Igg in Patients With Bullous Pemphigoid, Archives of Dermatological Research (2018)
156. Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran, Acta Medica Iranica (2018)
157. Coexistence of Oral Lichen Planus and Pemphigus Vulgaris, Clinical Oral Investigations (2018)
158. Comparison of Ethylenediaminetetraacetic Acid-Treated Desmoglein Elisa and Conventional Desmoglein Elisa in the Evaluation of Pemphigus Vulgaris in Remission, Journal of the American Academy of Dermatology (2018)
159. Cryotherapy Plus Oral Zinc Sulfate Versus Cryotherapy Plus Placebo to Treat Common Warts: A Double Blind, Randomized, Placebo-Controlled Trial, International Journal of Women's Dermatology (2018)
160. Dermoscopic Findings in 126 Patients With Alopecia Areata: A Cross-Sectional Study, International Journal of Trichology (2018)
161. Effects of L-Carnitine Supplementation on Biomarkers of Oxidative Stress, Antioxidant Capacity and Lipid Profile, in Patients With Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled Trial, European Journal of Clinical Nutrition (2018)
162. International Bullous Diseases Group: Consensus on Diagnostic Criteria for Epidermolysis Bullosa Acquisita, British Journal of Dermatology (2018)
163. Oral Candida Colonization and Plaque Type Psoriasis: Is There Any Relationship?, Journal of investigative and clinical dentistry (2018)
164. Sixteen-Year History of Rituximab Therapy for 1085 Pemphigus Vulgaris Patients: A Systematic Review, International Immunopharmacology (2018)
165. The Association Between St18 Gene Polymorphism and Severe Pemphigus Disease Among Iranian Population, Experimental Dermatology (2018)
166. Treatment of Basal Cell Carcinoma: Is Intralesional Methotrexate an Option?, Journal of Dermatological Treatment (2018)
167. Ulcerated Necrobiosis Lipoidica: A Cutaneous Granulomatous Reaction Associated With Systemic B-Cell Lymphoma, Indian Journal of Dermatology# Venereology and Leprology (2018)
168. Adverse Reactions Associated With Intravenous Immunoglobulin Therapy in Patients With Dermatologic Diseases: An 11-Year Retrospective Study, Iranian Journal of Dermatology (2017)
169. Anagen Hair Loss, Anti-Desmoglein 1, and Pemphigus Disease Area Index: A Signifi Cant Relationship?; [Anagener Haarverlust, Anti-Desmoglein 1 Und Pemphigus Disease Area Index: Ein Signifi Kanter Zusammenhang?], JDDG - Journal of the German Society of Dermatology (2017)
170. Autosomal Recessive Congenital Ichthyosis: Cers3 Mutations Identified by a Next Generation Sequencing Panel Targeting Ichthyosis Genes, European Journal of Human Genetics (2017)
171. Characteristic Features of Cutaneous Melanoma in a Dermatology Referral Centre in Tehran, Iran, Australasian Journal of Dermatology (2017)
172. Cheilitis in Acne Vulgaris Patients With No Previous Use of Systemic Retinoid Products, Australasian Journal of Dermatology (2017)
173. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study, SKINmed (2017)
174. Evaluation of Patients Visiting the Dermatology Emergency Unit of a University Dermatology Hospital in Tehran, Iran, Acta Medica Iranica (2017)
175. Hydrocortisone 1% Cream and Sertaconazole 2% Cream to Treat Facial Seborrheic Dermatitis: A Double-Blind, Randomized Clinical Trial, International Journal of Women's Dermatology (2017)
176. Neurological Diseases and Bullous Pemphigoid: A Case-Control Study in Iranian Patients, Indian Journal of Dermatology# Venereology and Leprology (2017)
177. Persistent Lip Enlargement: An Unusual Presentation of Lupus Erythematosus, International Journal of Women's Dermatology (2017)
178. Rituximab Administration in a Patient With Pemphigus Vulgaris Following Reactivation of Occult Hepatitis B Virus Infection, Dermatology Online Journal (2017)
179. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
180. Superficial Plantar Angiomyxoma in a Young Man, Australasian Journal of Dermatology (2017)
181. Blockage of T Cell Activation Via Anti-Cd40 and Anti-Cd154 Monoclonal Antibodies Can Possibility Treat Alopecia Areata, Scandinavian Journal of Immunology (2016)
182. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata, Scandinavian Journal of Immunology (2016)
183. Evaluation of Prolactin Levels in Patients With Newly Diagnosed Pemphigus Vulgaris and Its Correlation With Pemphigus Disease Area Index, International Journal of Women's Dermatology (2016)
184. Immunologic Prediction of Relapse in Patients With Pemphigus Vulgaris (Pv) in Clinical Remission, Journal of the American Academy of Dermatology (2016)
185. Koebner Phenomenon in Pemphigus Vulgaris Patients, JAAD Case Reports (2016)
186. Krt5 and Krt14 Mutations in Epidermolysis Bullosa Simplex With Phenotypic Heterogeneity, and Evidence of Semidominant Inheritance in a Multiplex Family, Journal of Investigative Dermatology (2016)
187. Longitudinal Melanonychia in an Iranian Population: A Study of 96 Patients, International Journal of Women's Dermatology (2016)
188. Prolactin Level Changes in Pemphigus Vulgaris: A Cohort Study, Iranian Journal of Dermatology (2016)
189. Temporal Course of Avascular Femoral Head Necrosis in Patients With Pemphigus Vulgaris; [Zeitlicher Verlauf Der Avaskularen Nekrose Des Huftkopfes Bei Patienten Mit Pemphigus Vulgaris], JDDG - Journal of the German Society of Dermatology (2016)
190. The Dual Nature of Retinoic Acid in Pemphigus and Its Therapeutic Potential: Special Focus on All-Trans Retinoic Acid, International Immunopharmacology (2016)
191. Trauma-Induced Pemphigus: A Case Series of 36 Patients; [Trauma-Induzierter Pemphigus: Eine Fallserie Von 36 Patienten], JDDG - Journal of the German Society of Dermatology (2016)
192. Validity of Trichoscopy in the Diagnosis of Primary Cicatricial Alopecias, International Journal of Dermatology (2016)
193. A 52 Year Old Man With Cerebriform Vegetating Masses on the Scalp, Clinical Cases in Autoimmune Blistering Diseases (2015)
194. Diagnostic Accuracy of Bp180 Nc16a and Bp230-C3 Elisa in Serum and Saliva of Patients With Bullous Pemphigoid, Clinical and Experimental Dermatology (2015)
195. Direct Immunofluorescence for Immunobullous and Other Skin Diseases, Expert Review of Clinical Immunology (2015)
196. Evaluation of Antioxidant Enzyme Activity and Antioxidant Capacity in Patients With Newly Diagnosed Pemphigus Vulgaris, Clinical and Experimental Dermatology (2015)
197. Lipoid Proteinosis: Phenotypic Heterogeneity in Iranian Families With C.507Delt Mutation in Ecm1, Experimental Dermatology (2015)
198. Loss of Normal Anagen Hair in Pemphigus Vulgaris, Clinical and Experimental Dermatology (2015)
199. Paraneoplastic Pemphigus Associated With Inflammatory Myofibroblastic Tumour of the Mediastinum: A Favourable Response to Treatment and Review of the Literature, Australasian Journal of Dermatology (2015)
200. Rituximab Therapy Improves Recalcitrant Pemphigus Vulgaris, EXCLI Journal (2015)
201. Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment, BioMed Research International (2015)